Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

INSULIN PUMPS (EXTERNAL) - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 18 companies including many key and niche players such as Animas Corporation, Debiotech S.A., F. Hoffmann-La Roche, Ltd., Disetronic Medical Systems, Inc, Insulet Corporation, Medtronic Diabetes, Nilimedix Ltd, Nipro Diabetes Systems, Sooil Development Co. Ltd., and Starbridge Systems Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1511
Price : $4500
Companies : 18
Pages : 150
Date : October 2010
Market Data Tables : 25

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  INSULIN PUMPS (EXTERNAL) (Complete Report) Pages : 150   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......13 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
  
  2. INDUSTRY OVERVIEW........44 $595  
   Increasing Diabetes Prevalence – A Major Growth Propeller........4
Insulin Therapy for Diabetes Management........4
1$100
   Insulin Pumps: The Convenient Substitute for Insulin Injection........5
Current and Future Analysis........5
The United States – The Largest Market for External Insulin Pumps........5
1$100
   European Market Characterized by Less Pump Users........6
Competitive Scenario........6
Table 1: World Insulin Pumps Market by Leading Players (2009): Market Share Breakdown for Medtronic, Roche,Insulet and Others (includes corresponding Graph/Chart)........6
1$350
   Tough Ground for New Entrants........7
1$100
  3. MARKET TRENDS AND ISSUES........84 $295  
   Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market........8
Innovative Features Spruce Up the Market for Insulin Pumps........8
1$100
   Combination Products in Rage........91$100
   Expiry of Warranty Provides New Opportunities to Insulin Pump Makers........10
Customer Satisfaction: Crucial to Stay Competitive........10
1$100
   Insulin Pump Training - Not Receiving Adequate Attention........11
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged........11
Debate On Superiority of Pump Therapy Over MDI Continues........11
Teenagers Outdo Adults in Controlling Diabetes........11
1$100
  4. DIABETES & INSULIN – AN ABSTRACT........125 $395  
   Diabetes - A Fatal Disease........12
Risk Factors for Diabetes........12
Types of Diabetes........12
1$100
   Long Term Complications of Diabetes........13
Testing Sugar Levels: Easy and Accurate........13
Insulin........13
Pancreas: The Main Source of Insulin in Human Body........13
1$100
   Types of Insulin........14
Types of Insulin & Onset of Action........14
Goal of Insulin Therapy........14
1$100
   Insulin Delivery Systems........15
a. Syringes........15
b. Insulin Pens........15
1$100
   c. Jet Injectors........16
d. Tablets........16
e. External Insulin Pumps........16
Insulin Delivery Technologies........16
1$100
  5. PRODUCT OVERVIEW........176 $395  
   Evolution of Insulin Pumps........17
Insulin Pump - A Replica of Pancreas........17
Advantages........17
More Accurate and Consistent........17
1$100
   Enhances Blood Sugar Control in Pediatric Patients........18
Adjusting Time Zones While Traveling........18
Improves Quality of Life........18
Components of Insulin Pump........18
1$100
   How Does an Insulin Pump Work?........19
Insulin Pump Delivery Rates........19
Guidelines for Insulin Pump Usage........19
1$100
   Disadvantages/Risks Involved in the Usage of Insulin Pumps........20
High Cost........20
High Involvement........20
1$100
   Diabetic Ketoacidosis Risk........21
Glucose Testing at Regular Intervals........21
Regular Rotation of Infusion Set........21
Carrying Back-up Kit........21
Regular Refilling of Pump........21
Lantus: A Threat to Insulin Pump Manufacturers........21
1$100
   Centers for Medicare & Medicaid Services (CMS): Funding Organizations........22
1$100
  6. PRODUCT INNOVATIONS/INTRODUCTIONS........23   
   JDRF Develops Novel Technology for Type 1 Diabetes........23
Johnson & Johnson Medical India to Unveil Insulin Pumps in India........23
Debiotech and STMicroelectronics Introduced First Prototype of a Miniaturized,
  Disposable Insulin Nanopump........23
ROCHE Launches Accu-Chek Spirit........23
1$100
   Smith Medical Launches Cozmo in China........24
Industrial Scholar Devises Wristwatch Insulin Pump........24
Medtronic Unveils Arabic Language Insulin Pump........24
Medtronic Launches New Diabetes Monitoring System........24
1$100
  7. PRODUCT INNOVATIONS/INTRODUCTIONS IN THE RECENT PAST – A PERSPECTIVE BUILDER........254 $295  
   Debiotech Unveils Miniaturized Insulin Nanopump™........25
Roche Diagnostics Introduces New Insulin Pump System........25
Medtronic Releases New Diabetes Device........25
SpectRx Unveils SimpleChoice Infusion Sets........25
Nipro Diabetes Unveils Amigo® Insulin Pump........25
1$100
   SpectRx Introduces New Series of Insulin Pumps........26
New OmniPod Insulin Management System from Insulet........26
New 1250 Insulin Pumps from Animas........26
1$100
   Smiths Medical Launches Insulin Pumps in Germany........27
Becton, Dickinson Unveils the First Intelligent Pump........27
Medtronic Rolls Out New Pump Systems........27
Accu-Science Launches New Insulin Pumps in Ireland........27
New Insulin Pump Infusion Sets from SpectRx........27
1$100
   Roche Expands Accu-Chek Product Line........28
Cozmo® Insulin Pump Technology from Smiths........28
Medtronic Unveils Paradigm 512 and 712........28
SpectRx Launches Disposable Infusion Set........28
1$100
  8. RECENT INDUSTRY ACTIVITY........295 $395  
   JDRF Enters into Partnership with Animas........29
JDRF Collaborates with BD........29
Nilimedix Inks Strategic Distribution Agreement with Sinopharm........29
1$100
   Roche Takes Over Medingo........30
Insulet Inks Exclusive Distribution Agreement with Ypsomed........30
NiliMedix Obtains CE Mark Certification for NiliPatch Disposable Insulin Pump........30
Medingo Obtains FDA Approval for Marketing Insulin Micropump........30
Eli Lilly and Medtronic Enter into a Strategic Marketing Alliance........30
1$100
   Medtronic Acquires Certain Assets from PreciSense........31
Insulet Wins CE Mark Approval for OmniPod® Insulin Management System........31
DexCom and Animas Amend Insulin Pump Joint Development Deal........31
Medtronic Inaugurates Diabetes Therapy Management and Education Center........31
1$100
   Smiths Medical Ceases Insulin Pumps Sale, Exits Diabetes Business........32
Alere Medical Acquires Matria Healthcare........32
Smiths Medical Acquires Zhejiang Zheda Medical Instrument........32
Animas Partners with DexCom........32
1$100
   Animas Recalls Insulin Pumps with Faulty Battery Cap........33
VitalCare Announces Launch of Diabetes Treatment Centers Across the US........33
Novo Nordisk Receives FDA Approval for Pediatric Application of NovoLog®........33
1$100
  9. CORPORATE ACTIVITY IN THE RECENT PAST – A PERSPECTIVE BUILDER........349 $595  
   Insulet Inks Agreement with DexCom........34
Medtronic Partners with LifeScan........34
Phluid Corporation Inks Agreement with Syprosoft........34
Insulet Partners with Flextronics........34
Medco Absorbs PolyMedica........34
Debiotech Allies with STMicroelectronics........34
1$100
   NiliMedix Seeks FDA Approval........35
NiliMedix Attains CE Approval........35
NationsHealth Pockets Diabetes Care & Education........35
SpectRx, Inc. Divests Insulin Pump Business........35
Medtronic Obtains FDA Clearance for MiniMed Paradigm® Diabetes Device........35
FDA Approves Smiths Medical’s Updated CozMore System........35
1$100
   Matria Healthcare Acquires CorSolutions........36
Johnson & Johnson Acquires Animas........36
MiniMed Signs an Agreement with Smiths Medical........36
Starbridge Collaborates with Medical House Products........36
1$100
   Medtronic Extends Educational Support for Diabetes Management........37
ADA Calls the Government to Rescind Cuts to Maine Care........37
Insulet Partners with Solectron........37
1$100
   Animas’ IR 1250 Pump Gains FDA Approval........38
Nilimedix Awaits Grant from Chief Scientist........38
Animas Recalls Its Newly Released Insulin Pumps........38
Animas Teams Up with Debiotech........38
1$100
   Deltec Turns Into Smiths Medical........39
Smiths’ Products Gain FDA Approval........39
Cigna Detaches Dana........39
Smiths Collaborates with TheraSense........39
1$100
   Animas’ Insulin Pumps Receive Nod from Health Canada........40
Smiths Partners with Abbott........40
Cleo 90 Receives FDA Approval........40
Animas’ Insulin Pump Receives the Approval of Israeli Government........40
Animas Relocates Headquarters........40
FDA Bans Disetronic in the US........40
1$100
   Animas Expands........41
Medtronic Retracts Infusion Sets........41
Animas Acquires Cygnus........41
Novo Nordisk Signs an Agreement with Medtronic........41
1$100
   Roche Acquires Disetronic........42
1$100
  10. FOCUS ON KEY PLAYERS........433 $295  
   Animas Corp. (USA)........43
Debiotech S.A. (Switzerland)........43
F. Hoffmann-La Roche, Ltd. (Switzerland)........43
1$100
   Disetronic Medical Systems, Inc. (USA)........44
Insulet Corporation (USA)........44
Medtronic Diabetes (USA)........44
1$100
   Nilimedix Ltd (Israel)........45
Nipro Diabetes Systems (USA)........45
Sooil Development Co. Ltd. (Korea)........45
Starbridge Systems Ltd. (UK)........45
1$100
  11. GLOBAL MARKET PERSPECTIVE........46   
   Table 2: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........461$350
   Table 3: World Historic Review for Insulin Pumps (External) by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........471$350
   Table 4: World 11-Year Perspective for Insulin Pumps by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for2005, 2010 & 2015 (includes corresponding Graph/Chart)........48
1$350
  12. THE UNITED STATES........493 $595  
   A. Market Analysis........49
External Insulin Pumps: A Key Mechanism for Insulin Delivery........49
Surging Diabetic Population Keeps Demand Ticking for Insulin Pumps........49
1$100
   Table 5: Diabetes Prevalence in the US by Type: 2008 (includes corresponding Graph/Chart)........50
Competitive Scenario........50
Table 6: US Insulin Pumps Market by Leading Players (2008): Market Share Breakdown of for Medtronic, Animas, Insulet, and Others (includes corresponding Graph/Chart)........50
Major Insulin Pump Systems: A Comparison........50
1$350
   B. Market Analytics........51
Table 7: The US Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........51

Table 8: The US Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........51
1$350
  13. EUROPE........524 $595  
   A. Market Analysis........52
Though Late, Insulin Pump Starts Gaining Favor Among Europeans........52
1$100
   B. Market Analytics........53
Table 9: European Recent Past, Current & Future Market Analysis for Insulin Pumps (External) by Geographic Region – France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........53
1$350
   Table 10: European Historic Review for Insulin Pumps (External) by Geographic Region – France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........541$350
   Table 11: European 11-Year Perspective for Insulin Pumps by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, and Rest of Europe Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........55
1$350
  13a. FRANCE........562 $595  
   Market Analysis........56
Table 12: French Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........56
1$350
   Table 13: French Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........57
1$350
  13b. GERMANY........582 $595  
   Market Analysis........58
Table 14: German Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........58
1$350
   Table 15: German Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........59
1$350
  13c. ITALY........602 $595  
   Market Analysis........60
Table 16: Italian Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........60
1$350
   Table 17: Italian Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........61
1$350
  13d. THE UNITED KINGDOM........623 $595  
   A. Market Analysis........62
Current and Future Analysis........62
INPUT (The Insulin Pump Therapy Group)........62
NICE (National Institute of Clinical Excellence)........62
1$100
   B. Market Analytics........63
Table 18: The UK Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........63
1$350
   Table 19: The UK Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........64
1$350
  13e. SPAIN........652 $595  
   Market Analysis........65
Table 20: Spanish Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........65
1$350
   Table 21: Spanish Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........66
1$350
  13f. REST OF EUROPE........673 $595  
   A. Market Analysis........67
Current and Future Analysis........67
Russia........67
Lack of Awareness: A Major Growth Restraint........67
1$100
   B. Market Analytics........68
Table 22: Rest of Europe Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........68
1$350
   Table 23: Rest of Europe Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........69
1$350
  14. REST OF WORLD........704 $595  
   A. Market Analysis........70
Current and Future Analysis........70
Review of Select Countries/Regions........70
India........70
Insulin Pumps Gather Momentum........70
Medtronic: The Undisputed Market Leader........70
1$100
   China........71
Overview........71
Competition........71
Brazil........71
1$100
   B. Market Analytics........72
Table 24: Rest of World Recent Past, Current & Future Market Analysis for Insulin Pumps by Product – External Insulin Pumps Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........72
1$350
   Table 25: Rest of World Historic Review for Insulin Pumps (External) Market with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)........731$350
COMPETITION 66$995
  
Total Companies Profiled: 18 (including Divisions/Subsidiaries - 21)

Region/Country                 Players


The United States                 11  
Japan                              1
Europe                             4
     The United Kingdom            1
     Rest of Europe                3
Asia-Pacific (Excluding Japan)     4
Middle-East                        1
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign